Virtual Medicinal Product (VMP)
-
Budesonide 2mg/application foam enema
Name Details
Current Name
Budesonide 2mg/application foam enema
|
Start Date
01-06-2023
|
End Date
|
Previous Name
Budesonide 2mg foam enema
|
Start Date
06-10-2009
|
End Date
31-05-2023
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- actuation
- Unit Dose UOM
- actuation
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Rectal
- Form
- Rectal foam
- Ontology Form/Route
- foamenema.rectal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A07EA06
BNF |
Current BNF
01050200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01050200
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
01050000
|
Start Date
04-12-2007
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
11550711000001105 |
13-06-2007 |
|
VMP Ingredients
VMP ingredients table
Budesonide |
Based on Ingredient Substance |
|
2 mg |
1 actuation |
Name
Budesonide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Budesonide
-
VMP
(Current) Budesonide 2mg/application foam enema
Virtual Medicinal Product Pack (VMPP) Information